Amgen (AMGN) FY2022 results: revenue $26.3 billion, up 1.3% on the year
Amgen Inc. (AMGN) reported revenue of $26.3 billion for fiscal 2022, the year ended 31 December 2022, up 1.3% on the year before. Net income was $6.6 billion, up 11.2%, and diluted earnings per share $12.11. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2023.
Revenue
$26.3 billion
+1.3% on the year
FY2015FY2022
Operating margin
36.3%
29.4% a year earlier
FY2015FY2022
Net income
$6.6 billion
+11.2% on the year
FY2015FY2022
Diluted EPS
$12.11
+17.8% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
9,721
9,261
10,497
+5.0%
Capital expenditure
936
880
608
+6.4%
Free cash flow
8,785
8,381
9,889
+4.8%
Free cash flow margin
33.4%
32.3%
38.9%
Cash from investing
-6,044
733
-5,401
Cash from financing
-4,037
-8,271
-4,867
Depreciation and amortisation
3,417
3,398
3,601
+0.6%
Share-based compensation
401
341
330
+17.6%
Buybacks
6,360
4,975
3,486
+27.8%
Dividends paid
4,196
4,013
3,755
+4.6%
Dividend per share
$7.95
$7.22
$6.56
+10.1%
Diluted shares, weighted
541m
573m
590m
-5.6%
Shares outstanding at period end
534m
558m
578m
-4.4%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
3,661
6,700
9,409
-45.4%
Debt
38,945
33,309
32,986
+16.9%
Operating lease liabilities
539
525
306
+2.7%
Other liabilities
21,976
20,631
20,247
+6.5%
Total liabilities and equity
65,121
61,165
62,948
+6.5%
Fixed assets
5,427
5,184
4,889
+4.7%
Goodwill
15,529
14,890
14,689
+4.3%
Intangible assets
16,080
15,182
16,587
+5.9%
Investments
1,676
48.0
4,381
+3,391.7%
Cash and equivalents
7,629
7,989
6,266
-4.5%
Receivables
5,563
4,895
4,525
+13.6%
Inventory
4,930
4,086
3,893
+20.7%
Other assets
8,287
8,891
7,718
-6.8%
Total assets
65,121
61,165
62,948
+6.5%
10-K for the year ended 31 December 2022, filed 9 February 2023: the filing.